We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BARR: GENERIC BIOLOGICS SHOULD BE SUBSTITUTABLE
BARR: GENERIC BIOLOGICS SHOULD BE SUBSTITUTABLE
June 18, 2004
Generic firms can develop generic biologics using available raw materials, and the FDA can approve the products as fully substitutable for their brand equivalents under current regulations, according to Barr Pharmaceuticals’ executives, who challenged some commonly held perceptions about the complex molecules.